The DOI matches its Crossref record; 94 of the 94 references it cites were found in a registry or an index.
Clinical and economic burden of antimicrobial resistance
Abstract
Knowledge of the clinical and economic impact of antimicrobial resistance is useful to influence programs and behavior in healthcare facilities, to guide policy makers and funding agencies, to define the prognosis of individual patients and to stimulate interest in developing new antimicrobial agents and therapies. There are a variety of important issues that must be considered when designing or interpreting studies into the clinical and economic outcomes associated with antimicrobial resistance. One of the most misunderstood issues is how to measure cost appropriately. Although imperfect, existing data show that there is an association between antimicrobial resistance in Staphylococcus aureus, enterococci and Gram-negative bacilli and increases in mortality, morbidity, length of hospitalization and cost of healthcare. Patients with infections due to antimicrobial-resistant organisms have higher costs (US $6,000-30,000) than do patients with infections due to antimicrobial-susceptible organisms; the difference in cost is even greater when patients infected with antimicrobial-resistant organisms are compared with patients without infection. Given limited budgets, knowledge of the clinical and economic impact of antibiotic-resistant bacterial infections, coupled with the benefits of specific interventions targeted to reduce these infections, will allow for optimal control and improved patient safety. In this review, the authors discuss a variety of important issues that must be considered when designing or interpreting studies of the clinical and economic outcomes associated with antimicrobial resistance. Representative literature is reviewed regarding the associations between antimicrobial resistance in specific pathogens and adverse outcomes, including increased mortality, length of hospital stay and cost.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Charlson, M. E., Pompei, P., Ales, K. L., & MacKenzie, C. R. (1987) · Journal of Chronic Diseases · doi:10.1016/0021-9681(87)90171-8 · Cited by 49,742
APACHE II: A severity of disease classification system
KNAUS, W. A., DRAPER, E. A., WAGNER, D. P., & ZIMMERMAN, J. E. (1985) · Critical Care Medicine · doi:10.1097/00003246-198510000-00009 · Cited by 13,664
Methods for the Economic Evaluation of Health Care Programmes
Drummond, M. E., Sculpher, M. J., Torrance, G. W., O’Brien, B. J., & Stoddart, G. L. (2005) · doi:10.1093/oso/9780198529446.001.0001 · Cited by 13,648
APACHE II-A Severity of Disease Classification System: Reply
Knaus, W. A., Draper, E. A., Wagner, D. P., & Zimmerman, J. E. (1986) · Critical Care Medicine · doi:10.1097/00003246-198608000-00028 · Cited by 13,376
System, A. R. F. T. N. (2003) · American Journal of Infection Control · doi:10.1016/j.ajic.2003.09.002 · Cited by 2,915
System, A. R. F. T. N. (2004) · American Journal of Infection Control · doi:10.1016/j.ajic.2004.10.001 · Cited by 2,342
Cosgrove, S. E., Sakoulas, G., Perencevich, E. N., Schwaber, M. J., Karchmer, A. W., & Carmeli, Y. (2003) · Clinical Infectious Diseases · doi:10.1086/345476 · Cited by 1,964
Self-citationNaimi, T. S. (2003) · JAMA · doi:10.1001/jama.290.22.2976 · Cited by 1,688
Genome and virulence determinants of high virulence community-acquired MRSA
Baba, T., Takeuchi, F., Kuroda, M., Yuzawa, H., Aoki, K.-I., Oguchi, A., Nagai, Y., Iwama, N., Asano, K., Naimi, T., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08713-5 · Cited by 1,370
Kreger, B. E., Craven, D. E., & McCabe, W. R. (1980) · The American Journal of Medicine · doi:10.1016/0002-9343(80)90102-3 · Cited by 1,314
The Distinction Between Cost and Charges
FINKLER, S. A. (1982) · Annals of Internal Medicine · doi:10.7326/0003-4819-96-1-102 · Cited by 1,052
The Epidemiology and Control of Acinetobacter baumannii in Health Care Facilities
Fournier, P. E., Richet, H., & Weinstein, R. A. (2006) · Clinical Infectious Diseases · doi:10.1086/500202 · Cited by 995
A chronic disease score from automated pharmacy data
Von Korff, M., Wagner, E. H., & Saunders, K. (1992) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(92)90016-g · Cited by 961
Engemann, J. J., Carmeli, Y., Cosgrove, S. E., Fowler, V. G., Bronstein, M. Z., Trivette, S. L., Briggs, J. P., Sexton, D. J., & Kaye, K. S. (2003) · Clinical Infectious Diseases · doi:10.1086/367653 · Cited by 934
Self-citationCosgrove, S. E., Qi, Y., Kaye, K. S., Harbarth, S., Karchmer, A. W., & Carmeli, Y. (2005) · Infection Control & Hospital Epidemiology · doi:10.1086/502522 · Cited by 856
Self-citationLautenbach, E., Patel, J. B., Bilker, W. B., Edelstein, P. H., & Fishman, N. O. (2001) · Clinical Infectious Diseases · doi:10.1086/319757 · Cited by 747
Kang, C.-I., Kim, S.-H., Park, W. B., Lee, K.-D., Kim, H.-B., Kim, E.-C., Oh, M.-D., & Choe, K.-W. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.2.760-766.2005 · Cited by 692
The Impact of Antimicrobial Resistance on Health and Economic Outcomes
Eliopoulos, G. M., Cosgrove, S. E., & Carmeli, Y. (2003) · Clinical Infectious Diseases · doi:10.1086/375081 · Cited by 637
Self-citationSchwaber, M. J., & Carmeli, Y. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm318 · Cited by 626
Multidrug-Resistant Pseudomonas aeruginosa : Risk Factors and Clinical Impact
Aloush, V., Navon-Venezia, S., Seigman-Igra, Y., Cabili, S., & Carmeli, Y. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.1.43-48.2006 · Cited by 617
Levin, A. S., Barone, A. A., Penço, J., Santos, M. V., Marinho, I. S., Arruda, E. A. G., Manrique, E. I., & Costa, S. F. (1999) · Clinical Infectious Diseases · doi:10.1086/514732 · Cited by 612
Lodise, T. P., McKinnon, P. S., Swiderski, L., & Rybak, M. J. (2003) · Clinical Infectious Diseases · doi:10.1086/375057 · Cited by 604
Levine, D. P., Fromm, B. S., & Reddy, B. R. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-9-674 · Cited by 577
Paterson, D. L., Ko, W.-C., Von Gottberg, A., Mohapatra, S., Casellas, J. M., Goossens, H., Mulazimoglu, L., Trenholme, G., Klugman, K. P., Bonomo, R. A., et al. (2004) · Clinical Infectious Diseases · doi:10.1086/420816 · Cited by 571
Kang, C., Kim, S., Kim, H., Park, S., Choe, Y., Oh, M., Kim, E., & Choe, K. (2003) · Clinical Infectious Diseases · doi:10.1086/377200 · Cited by 565
Health and Economic Impact of Surgical Site Infections Diagnosed after Hospital Discharge
Perencevich, E. N., Sands, K. E., Cosgrove, S. E., Guadagnoli, E., Meara, E., & Platt, R. (2003) · Emerging Infectious Diseases · doi:10.3201/eid0902.020232 · Cited by 512
Self-citationYu, V. L., Chiou, C. C. C., Feldman, C., Ortqvist, A., Rello, J., Morris, A. J., Baddour, L. M., Luna, C. M., Snydman, D. R., Ip, M., et al. (2003) · Clinical Infectious Diseases · doi:10.1086/377534 · Cited by 451
Mart??nez-Aguilar, G., Avalos-Mishaan, A., Hulten, K., Hammerman, W., Mason, E. O., & Kaplan, S. L. (2004) · The Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000133044.79130.2a · Cited by 416
Schwaber, M. J., Navon-Venezia, S., Kaye, K. S., Ben-Ami, R., Schwartz, D., & Carmeli, Y. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.4.1257-1262.2006 · Cited by 416
Multidrug-resistant Acinetobacter Infection Mortality Rate and Length of Hospitalization
Sunenshine, R. H., Wright, M.-O., Maragakis, L. L., Harris, A. D., Song, X., Hebden, J., Cosgrove, S. E., Anderson, A., Carnell, J., Jernigan, D. B., et al. (2007) · Emerging Infectious Diseases · doi:10.3201/eid1301.060716 · Cited by 411
Self-citationlezzoni, L. I. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03550190064046 · Cited by 408
Gonzalez, C., Rubio, M., Romero-Vivas, J., Gonzalez, M., & Picazo, J. J. (1999) · Clinical Infectious Diseases · doi:10.1086/313440 · Cited by 407
Vancomycin for Staphylococcus aureus endocarditis in intravenous drug users
Small, P. M., & Chambers, H. F. (1990) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.34.6.1227 · Cited by 399
Iezzoni, L. I. (1997) · JAMA · doi:10.1001/jama.278.19.1600 · Cited by 388
Rice, L. B., Willey, S. H., Papanicolaou, G. A., Medeiros, A. A., Eliopoulos, G. M., Moellering, R. C., & Jacoby, G. A. (1990) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.34.11.2193 · Cited by 376
Health and Economic Outcomes of Antibiotic Resistance in Pseudomonas aeruginosa
Carmeli, Y., Troillet, N., Karchmer, A. W., & Samore, M. H. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.10.1127 · Cited by 363
Kim, Y.-K., Pai, H., Lee, H.-J., Park, S.-E., Choi, E.-H., Kim, J., Kim, J.-H., & Kim, E.-C. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.5.1481-1491.2002 · Cited by 357
Mortality Associated with Nosocomial Bacteremia Due to Methicillin-Resistant Staphylococcus aureus
Romero-Vivas, J., Rubio, M., Fernandez, C., & Picazo, J. J. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/21.6.1417 · Cited by 318
Vancomycin-Resistant Enterococcal Bacteremia: Natural History and Attributable Mortality
Edmond, M. B., Ober, J. F., Dawson, J. D., Weinbaum, D. L., & Wenzel, R. P. (1996) · Clinical Infectious Diseases · doi:10.1093/clinids/23.6.1234 · Cited by 301
Cosgrove, S. E., Kaye, K. S., Eliopoulous, G. M., & Carmeli, Y. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.2.185 · Cited by 299
Self-citationHarbarth, S., Rutschmann, O., Sudre, P., & Pittet, D. (1998) · Archives of Internal Medicine · doi:10.1001/archinte.158.2.182 · Cited by 267
Seifert, H., Strate, A., & Pulverer, G. (1995) · Medicine · doi:10.1097/00005792-199511000-00004 · Cited by 259
Linden, P. K., Pasculle, A. W., Manez, R., Kramer, D. J., Fung, J. J., Pinna, A. D., & Kusne, S. (1996) · Clinical Infectious Diseases · doi:10.1093/clinids/22.4.663 · Cited by 259
Health and Economic Outcomes of Vancomycin-Resistant Enterococci
Carmeli, Y., Eliopoulos, G., Mozaffari, E., & Samore, M. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.19.2223 · Cited by 249
Shurland, S., Zhan, M., Bradham, D. D., & Roghmann, M.-C. (2007) · Infection Control & Hospital Epidemiology · doi:10.1086/512627 · Cited by 236
The control of confounding by intermediate variables
Robins, J. (1989) · Statistics in Medicine · doi:10.1002/sim.4780080608 · Cited by 234
Fluoroquinolone-Resistant Pseudomonas aeruginosa: Assessment of Risk Factors and Clinical Impact
Gasink, L. B., Fishman, N. O., Weiner, M. G., Nachamkin, I., Bilker, W. B., & Lautenbach, E. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2005.11.029 · Cited by 206
Reed, S. D., Friedman, J. Y., Engemann, J. J., Griffiths, R. I., Anstrom, K. J., Kaye, K. S., Stryjewski, M. E., Szczech, L. A., Reller, L. B., Corey, G. R., et al. (2005) · Infection Control & Hospital Epidemiology · doi:10.1086/502523 · Cited by 200
Serotonin Toxicity Associated with the Use of Linezolid: A Review of Postmarketing Data
Lawrence, K. R., Adra, M., & Gillman, P. K. (2006) · Clinical Infectious Diseases · doi:10.1086/503839 · Cited by 200
Lee, N.-Y., Lee, H.-C., Ko, N.-Y., Chang, C.-M., Shih, H.-I., Wu, C.-J., & Ko, W.-C. (2007) · Infection Control & Hospital Epidemiology · doi:10.1086/517954 · Cited by 198
Marchaim, D., Navon-Venezia, S., Schwaber, M. J., & Carmeli, Y. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01103-07 · Cited by 195
Hyle, E. P., Lipworth, A. D., Zaoutis, T. E., Nachamkin, I., Bilker, W. B., & Lautenbach, E. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.12.1375 · Cited by 194
Epidemiology and Clinical Outcomes of Patients with Multiresistant Pseudomonas aeruginosa
Harris, A., Torres‐Viera, C., Venkataraman, L., DeGirolami, P., Samore, M., & Carmeli, Y. (1999) · Clinical Infectious Diseases · doi:10.1086/514760 · Cited by 194
Impact of imipenem resistance on mortality in patients with Acinetobacter bacteraemia
Kwon, K. T., Oh, W. S., Song, J.-H., Chang, H.-H., Jung, S.-I., Kim, S.-W., Ryu, S. Y., Heo, S. T., Jung, D. S., Rhee, J.-Y., et al. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl499 · Cited by 188
McGregor, J. C., Kim, P. W., Perencevich, E. N., Bradham, D. D., Furuno, J. P., Kaye, K. S., Fink, J. C., Langenberg, P., Roghmann, M.-C., & Harris, A. D. (2005) · American Journal of Epidemiology · doi:10.1093/aje/kwi068 · Cited by 184
Self-citationThe cost of antibiotic resistance from a bacterial perspective
Björkman, J., & Andersson, D. I. (2000) · Drug Resistance Updates · doi:10.1054/drup.2000.0147 · Cited by 179
Bhavnani, S. M., Drake, J. A., Forrest, A., Deinhart, J. A., Jones, R. N., Biedenbach, D. J., & Ballow, C. H. (2000) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(99)00136-4 · Cited by 179
Blot, S., Vandewoude, K., & Colardyn, F. (2003) · Intensive Care Medicine · doi:10.1007/s00134-003-1648-8 · Cited by 177
Enterococcus faecium Bacteremia: Does Vancomycin Resistance Make a Difference?
Stosor, V., Peterson, L. R., Postelnick, M., & Noskin, G. A. (1998) · Archives of Internal Medicine · doi:10.1001/archinte.158.5.522 · Cited by 176
Risk Factors for Mortality in Staphylococcus aureus Bacteremia
Conterno, L. O., Wey, S. B., & Castelo, A. (1998) · Infection Control & Hospital Epidemiology · doi:10.1086/647704 · Cited by 175
Wang, J.-L., Chen, S.-Y., Wang, J.-T., Wu, G. H.-M., Chiang, W.-C., Hsueh, P.-R., Chen, Y.-C., & Chang, S.-C. (2008) · Clinical Infectious Diseases · doi:10.1086/527389 · Cited by 174
Lautenbach, E., Weiner, M., Nachamkin, I., Bilker, W., Sheridan, A., & Fishman, N. (2006) · Infection Control & Hospital Epidemiology · doi:10.1086/507274 · Cited by 159
Zaoutis, T. E., Goyal, M., Chu, J. H., Coffin, S. E., Bell, L. M., Nachamkin, I., McGowan, K. L., Bilker, W. B., & Lautenbach, E. (2005) · PEDIATRICS · doi:10.1542/peds.2004-1289 · Cited by 154
RecurrentStaphylococcus aureusBacteremia: Pulsed‐Field Gel Electrophoresis Findings in 29 Patients
Fowler, V. G., Kong, L., Corey, G. R., Gottlieb, G. S., McClelland, R. S., Sexton, D. J., Gesty‐Palmer, D., & Harrell, L. J. (1999) · The Journal of Infectious Diseases · doi:10.1086/314712 · Cited by 149
Raising Standards While Watching the Bottom Line Making a Business Case for Infection Control
Perencevich, E. N., Stone, P. W., Wright, S. B., Carmeli, Y., Fisman, D. N., & Cosgrove, S. E. (2007) · Infection Control and Hospital Epidemiology · doi:10.1086/521852 · Cited by 147
Self-citationBishop, E. J., Melvani, S., Howden, B. P., Charles, P. G. P., & Grayson, M. L. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.4.1599-1602.2006 · Cited by 146
Measuring the costs of nosocomial infections: Methods for estimating economic burden on the hospital
Haley, R. W. (1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)90341-t · Cited by 145
Clinical Outcomes of Bacteremic Pneumococcal Pneumonia in the Era of Antibiotic Resistance
Moroney, J. F., Fiore, A. E., Harrison, L. H., PATTERSON, J. E., Farley, M. M., Jorgensen, J. H., Phelan, M., Facklam, R. R., Cetron, M. S., Breiman, R. F., et al. (2001) · Clinical Infectious Diseases · doi:10.1086/322623 · Cited by 144
Miller, L. G., Quan, C., Shay, A. C., Mostafaie, K., Bharadwa, K., Tan, N., Matayoshi, K., Cronin, J., Tan, J. A., Tagudar, G., et al. (2007) · Clinical Infectious Diseases · doi:10.1086/511041 · Cited by 144
Lodise, T. P., McKinnon, P. S., Tam, V. H., & Rybak, M. J. (2002) · Clinical Infectious Diseases · doi:10.1086/339211 · Cited by 141
McClelland, R. S., Fowler, V. G., Sanders, L. L., Gottlieb, G. S., Kong, L., Sexton, D. J., Schmader, K. E., Lanclos, K., & Corey, G. R. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.11.1244 · Cited by 136
French, G. L., Cheng, A. F. B., Ling, J., Mo, P., & Donnan, S. (1990) · Journal of Hospital Infection · doi:10.1016/0195-6701(90)90120-d · Cited by 133
Roghmann, M. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.7.1001 · Cited by 130
Selvey, L. A., Whitby, M., & Johnson, B. C. (2000) · Infection Control and Hospital Epidemiology · doi:10.1086/501707 · Cited by 122
Hershow, R. C., Khayr, W. F., & Smith, N. L. (1992) · Infection Control and Hospital Epidemiology · doi:10.1086/646433 · Cited by 122
Reference Group Choice and Antibiotic Resistance Outcomes
Kaye, K. S., Engemann, J. J., Mozaffari, E., & Carmeli, Y. (2004) · Emerging infectious diseases · doi:10.3201/eid1006.020665 · Cited by 119
Ebbing, L., Metlay, J. P., Bilker, W. B., Edelstein, P. H., & Fishman, N. O. (2005) · Clinical Infectious Diseases · doi:10.1086/432940 · Cited by 118
Falagas, M. E. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl130 · Cited by 102
Niederman, M. S. (2005) · Clinical Infectious Diseases · doi:10.1086/499405 · Cited by 98
Quale, J. M., Landman, D., Bradford, P. A., Visalli, M. A., Ravishankar, J., Flores, C., Mayorga, D., Vangala, K., & Adedeji, A. (2002) · Clinical Infectious Diseases · doi:10.1086/342577 · Cited by 96
The Brooklyn Antibiotic Resistance Task Force (2002) · Infection Control and Hospital Epidemiology · doi:10.1086/502018 · Cited by 90
Fiore, A. E., Moroney, J. F., Farley, M. M., Harrison, L. H., PATTERSON, J. E., Jorgensen, J. H., Cetron, M. S., KOLCZAK, M. S., Breiman, R. F., & Schuchat, A. (2000) · Clinical Infectious Diseases · doi:10.1086/313606 · Cited by 89
Estimation of extra hospital stay attributable to nosocomial infections
Schulgen, G., Kropec, A., Kappstein, I., Daschner, F. D., & Schumacher, M. C. (2000) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(99)00182-1 · Cited by 83
Howard, D. H., Cordell, R. L., McGowan, J. E., Packard, R. M., Scott, R. D., Solomon, S. L., & the Workshop Group (2001) · Clinical Infectious Diseases · doi:10.1086/323758 · Cited by 80
Retrospective Evaluation of Therapies for Staphylococcus aureus Endocarditis
Gentry, C. A., Rodvold, K. A., Novák, R., Hershow, R. C., & Naderer, O. J. (1997) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/j.1875-9114.1997.tb03788.x · Cited by 72
Craven, D. E., Kollisch, N. R., Hsieh, C. R., Connolly, M. G., & McCabe, W. R. (1983) · The Journal of Infectious Diseases · doi:10.1093/infdis/147.1.137 · Cited by 72
Staphylococcus aureus Bacteremia: Factors Predicting Hospital Mortality
Mylotte, J. M., Aeschlimann, J. R., & Rotella, D. L. (1996) · Infection Control and Hospital Epidemiology · doi:10.1086/647264 · Cited by 62
Foglia, E. E., Fraser, V. J., & Elward, A. M. (2007) · Infection Control and Hospital Epidemiology · doi:10.1086/512628 · Cited by 61
McGregor, J. C., Perencevich, E. N., Furuno, J. P., LANGENBERG, P. W., Flannery, K., Zhu, J., Fink, J. C., Bradham, D. D., & Harris, A. D. (2006) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2006.01.016 · Cited by 61
Self-citationComparison of methicillin-resistant and methicillin-sensitive Staphylococcus aureus bacteremia
Lewis, E., & Saravolatz, L. D. (1985) · American Journal of Infection Control · doi:10.1016/s0196-6553(85)80011-0 · Cited by 57
Marty, L., Flahault, A., Suárez, B., Caillon, J., Hill, C., & Andremont, A. (1993) · Intensive Care Medicine · doi:10.1007/bf01690549 · Cited by 48
Excess Shock and Mortality in Staphylococcus aureus Related to Methicillin Resistance
Perencevich, E. N. (2000) · Clinical Infectious Diseases · doi:10.1086/317433 · Cited by 23
Self-citationThe appropriateness of initial vancomycin dosing.
Rodman, D. P., McKnight, J. T., Rogers, T., & Robbins, M. (1994) · PubMed · Cited by 20
Hamilton, K. W., Bilker, W. B., & Lautenbach, E. (2007) · Infection Control and Hospital Epidemiology · doi:10.1086/518751 · Cited by 17
Cited by
An overview of the antimicrobial resistance mechanisms of bacteria
C Reygaert, W., & Department of Biomedical Sciences, O. U. W. B. S. O. M. (2018) · AIMS Microbiology · doi:10.3934/microbiol.2018.3.482 · Cited by 1,893
Hypervirulent Klebsiella pneumoniae
Russo, T. A., & Marr, C. M. (2019) · Clinical Microbiology Reviews · doi:10.1128/cmr.00001-19 · Cited by 1,311
Chemical use in salmon aquaculture: A review of current practices and possible environmental effects
Burridge, L., Weis, J. S., Cabello, F., Pizarro, J., & Bostick, K. (2010) · Aquaculture · doi:10.1016/j.aquaculture.2010.05.020 · Cited by 842
Phage selection restores antibiotic sensitivity in MDR Pseudomonas aeruginosa
Chan, B. K., Sistrom, M., Wertz, J. E., Kortright, K. E., Narayan, D., & Turner, P. E. (2016) · Scientific Reports · doi:10.1038/srep26717 · Cited by 715
Antimicrobial Stewardship: Fighting Antimicrobial Resistance and Protecting Global Public Health
Majumder, M. A. A., Rahman, S., Cohall, D., Bharatha, A., Singh, K., Haque, M., & Gittens-St Hilaire, M. (2020) · Infection and Drug Resistance · doi:10.2147/idr.s290835 · Cited by 633
Metadata
- Authors
- Maragakis, L. L., Perencevich, E. N., & Cosgrove, S. E.
- Venue
- Expert Review of Anti-infective Therapy
- Publisher
- Informa UK Limited
- Published
- 2008-10
- Volume
- 6
- Issue
- 5
- Pages
- 751-763
- ISSN
- 1478-7210 (ISSN-L)
- 1744-8336
- OpenAlex
- W1963994312
- Cited by
- 329
- References
- 94
- FWCI
- 17.59
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.